Literature DB >> 18394198

Vitrectomy combined with glial tissue removal at the optic pit in a patient with optic disc pit maculopathy: a case report.

Makoto Inoue1, Kei Shinoda, Susumu Ishida.   

Abstract

INTRODUCTION: We present a case of a man with optic disc pit maculopathy, whose vision improved after vitrectomy combined with glial tissue removal from the optic pit area, and without the use of photocoagulation. CASE
PRESENTATION: A 45-year-old man complained of blurred vision, and ophthalmoscopy revealed a retinal detachment and retinoschisis extending from an optic disc pit through the macula in his left eye. He was diagnosed with optic disc pit maculopathy, and vitrectomy was performed. A posterior vitreous detachment was created, glial tissue at the optic pit was removed, and octafluoropropane (C3F8) was injected as a gas tamponade. The retinal detachment and retinoschisis disappeared after six months, and vision improved to 20/20 without any visual field defects (Goldmann perimetry). A cataractous lens was extracted 2 years after the vitrectomy, and vision has remained 20/20 for 10 years without any recurrence.
CONCLUSION: The removal of glial tissue during vitrectomy may be beneficial in patients with optic disc pit maculopathy.

Entities:  

Year:  2008        PMID: 18394198      PMCID: PMC2323014          DOI: 10.1186/1752-1947-2-103

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

Optic disc pit maculopathy is characterized by a congenital optic disc pit associated with a macular detachment and retinoschisis [1]. Focal laser photocoagulation of the temporal juxtapapillary retina or vitrectomy combined with a gas tamponade has been reported to be effective in treating this syndrome [1,2]. However, a relatively high incidence of recurrence has been reported after laser treatment alone [1]. A combination of both procedures has recently been reported to be an effective treatment [3]. Glial tissue is occasionally seen in the optic disc pit of patients with an optic disc pit or coloboma, but the reason for its development is unknown. We report a case of a man with optic disc pit maculopathy that was successfully treated using vitrectomy combined with the removal of glial tissue from the optic disc pit followed by the use a gas tamponade.

Case presentation

A 45-year-old Japanese man visited our clinic in September 1996 complaining of decreased vision in his left eye. His vision was decreased to 20/200, and ophthalmoscopy showed a retinal detachment involving the macula and a retinoschisis that extended from the optic disc pit through the macula in the left eye (Figure 1A). Glial tissue was seen at the optic disc pit but a retinal tear was not seen. Fluorescein angiography showed hypofluorescence of the optic disc pit, and multiple hyperfluorescent spots in the area of the macular lesion (Figure 2), but with no dye leakage. In the late phase, the optic disc pit and glial tissue became hyperfluorescent with mild dye leakage. He was diagnosed with optic disc pit maculopathy and vitrectomy was recommended.
Figure 1

Fundus photograph of the left eye before and after vitreous surgery. (A) Retinal detachment and retinal schisis can be seen with a double ring apparatus. Glial tissue can be seen at the optic pit (arrow). (B) Fundus photograph of the left eye four years after vitreous surgery. Retinal detachment and retinoschisis are absent and the excavation of the optic disc is clearly seen after removal of the glial tissue (arrow).

Figure 2

Fluorescein angiograms of the left eye. (A) Fluorescein angiogram in the early phase showing hypofluorescence at the optic pit and many hyperfluorescence spots can be seen in the macular lesion.(B) The hypofluorescence at the optic pit and glial tissue turned to hyperfluorescence with weak dye leakage in the late phase.

Fundus photograph of the left eye before and after vitreous surgery. (A) Retinal detachment and retinal schisis can be seen with a double ring apparatus. Glial tissue can be seen at the optic pit (arrow). (B) Fundus photograph of the left eye four years after vitreous surgery. Retinal detachment and retinoschisis are absent and the excavation of the optic disc is clearly seen after removal of the glial tissue (arrow). Fluorescein angiograms of the left eye. (A) Fluorescein angiogram in the early phase showing hypofluorescence at the optic pit and many hyperfluorescence spots can be seen in the macular lesion.(B) The hypofluorescence at the optic pit and glial tissue turned to hyperfluorescence with weak dye leakage in the late phase. After obtaining informed consent, vitrectomy was performed. A posterior vitreous detachment (PVD) was created by suction with a vitreous cutter until the 'fish-strike sign' was no longer seen. However, the vitreous cortex remained firmly attached at the optic disc pit. Neither condensed vitreous strands nor a residual Cloquet's canal was observed. It was decided intra-operatively that the glial tissue at the edge of the optic pit should be removed in order to remove the vitreous traction completely. Tapered forceps with a fine tip were used to avoid contact with the neural tissue at the edges of the optic pit. During this procedure, it was noted that the glial tissue was firmly attached to the temporal wall of the optic pit. An excavated space at the bottom of the optic pit was then clearly observed after removal of the tissue. The vitrectomy was completed with a 14% octafluoropropane (C3F8) gas tamponade, and the patient was instructed to maintain a face-down position for a week. Under these conditions, the retinal detachment and retinoschisis gradually decreased, and the retinal detachment and retinoschisis were absent six months postoperatively (Figure 1B). Vision improved to 20/20 without any visual field defects (Goldmann perimetry). The patient's vision deteriorated to 20/40 owing to a nuclear sclerosis cataract two years after the vitrectomy, and the lens was extracted. Vision has remained 20/20 for 10 years without any recurrence of the retinal detachment or retinoschisis. Optical coherence tomography (OCT) at this time did not detect a retinal detachment or retinoschisis, but two channels were seen running from the vitreous cavity to the longitudinal space of the optic nerve, possibly the subarachnoid space and the intraretinal space. The exit of these channels to the vitreous cavity was closed (Figure 3).
Figure 3

OCT image seven years after vitrectomy. Cross section of the temporal side of the optic disc showing two channels (arrowheads) connecting the vitreous cavity to the longitudinal space of the optic nerve and to the intraretinal space. The exit to the vitreous cavity is closed.

OCT image seven years after vitrectomy. Cross section of the temporal side of the optic disc showing two channels (arrowheads) connecting the vitreous cavity to the longitudinal space of the optic nerve and to the intraretinal space. The exit to the vitreous cavity is closed.

Discussion

The mechanism causing optic disc pit maculopathy has been considered to be vitreous traction on the optic disc pit. Bonnet [4] reported that 25 eyes with a macular detachment associated with an optic disc pit did not have a PVD, and two of the eyes had a reattachment of the macula after the development of a spontaneous PVD. Akiba et al [5] noted a residual Cloquet's canal moving in concert with a pulsating translucent membrane over the optic disc pit to cause anterior-posterior vitreous traction. However, the source of the subretinal fluid that causes the macular detachment and retinoschisis is still controversial, that is, whether it is vitreous fluid or cerebrospinal fluid [6]. The effectiveness of vitreous surgery to create a PVD around the optic disc with or without laser treatment has been examined [2,3]. The serous macular detachment associated with optic pits probably has a rhegmatogenous component. Thus, Postel et al [6] described a hole or tear in the diaphanous tissue overlying the optic pit in all of their seven cases. Todokoro et al [7], using careful OCT examinations, observed a cystic cavity covered with a superficial layer of optic disc tissue in a patient with a retinal detachment and retinoschisis that might correspond with the translucent membrane over the optic disc pit. OCT was not performed preoperatively in our case, and the connection between the glial tissue and the optic disc pit was only detected intra-operatively. We suggest that the glial tissue might have developed after continuous vitreous traction of the vitreous strand attached to the optic disc pit. Thus, removal of the glial tissue might have made it possible to remove the vitreous traction completely, or to seal the retinal break at the optic disc pit by removing the translucent membrane and glial tissue associated with the wound healing process to close the two intraretinal channels seen in the OCT images. On the other hand, the procedures might have enlarged the retinal break in the pit or damaged the nerve fibres at the optic disc. A permanent escape may be produced mechanically by displacement of the fluid during vitreous surgery and the use of a gas tamponade, and the retina flattens with time even though the flow from the subarachnoid space remains constant. A reservoir for the fluid from the subarachnoid space might be the vitreous cavity with an egress into it provided by some retinal fenestration near the optic nerve head [8]. We cannot make a strong conclusion on the efficacy of the removal of the glial tissue based on a single case. However, considering the absence of any side-effects, such as visual field defects or decreased vision, removal of glial tissue may be beneficial in selected cases. Additional studies with larger samples are needed to evaluate the efficacy of glial removal.

Conclusion

The removal of glial tissue during vitrectomy may be beneficial in patients with optic disc pit maculopathy.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

MI evaluated the patients and performed vitreous surgery. KS and SI reviewed the manuscript.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
  8 in total

1.  Optical coherence tomography in optic pit maculopathy managed with vitrectomy-laser-gas.

Authors:  José García-Arumí; Borja Corcóstegui Guraya; Ana Boixadera Espax; Vicente Martínez Castillo; Laura Sararols Ramsay; R Max Motta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-04-07       Impact factor: 3.117

2.  Serous detachment of the macula. Secondary to congenital pit of the optic nervehead.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1969-06       Impact factor: 5.258

3.  The etiology and treatment of macular detachment associated with optic nerve pits and related anomalies.

Authors:  E A Postel; J S Pulido; J A McNamara; M W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  1998

4.  Reattachment of retina and retinoschisis in pit-macular syndrome by surgically-induced vitreous detachment and gas tamponade.

Authors:  D Todokoro; S Kishi
Journal:  Ophthalmic Surg Lasers       Date:  2000 May-Jun

5.  Long-term results of vitrectomy without laser treatment for macular detachment associated with an optic disc pit.

Authors:  Akito Hirakata; Annabelle A Okada; Tetsuo Hida
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

6.  Vitreous findings in cases of optic nerve pits and serous macular detachment.

Authors:  J Akiba; A Kakehashi; T Hikichi; C L Trempe
Journal:  Am J Ophthalmol       Date:  1993-07-15       Impact factor: 5.258

7.  Serous macular detachment associated with optic nerve pits.

Authors:  M Bonnet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Unsuccessful vitrectomy without gas tamponade for macular retinal detachment and retinoschisis without optic disc pit.

Authors:  Kazuki Hotta
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2004 Jul-Aug
  8 in total
  8 in total

1.  Optic Pit Maculopathy: Clinical Features and Management Options.

Authors:  Prashanth G Iyer; Harry W Flynn; Kenneth C Fan; Audina M Berrocal; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2021-10-07

2.  Surgical approach and optic coherence tomographic evaluation of optic disc anomaly in association with serous macular detachment.

Authors:  Dilek Güven; Nihal Balcıoğlu; Cağrı Türker; Yasemin Baydar; Yekta Sendül
Journal:  Int Ophthalmol       Date:  2013-02-08       Impact factor: 2.031

Review 3.  Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options.

Authors:  Elad Moisseiev; Joseph Moisseiev; Anat Loewenstein
Journal:  Int J Retina Vitreous       Date:  2015-08-07

4.  Role of the Epipapillary Membrane in Maculopathy Associated with Cavitary Optic Disc Anomalies: Morphology, Surgical Outcomes, and Histopathology.

Authors:  Atsushi Tanaka; Wataru Saito; Satoru Kase; Kan Ishijima; Kousuke Noda; Susumu Ishida
Journal:  J Ophthalmol       Date:  2018-05-08       Impact factor: 1.909

5.  Surgical Options for Optic Disc Pit Maculopathy: Perspectives and Controversies.

Authors:  Salvador Pastor-Idoate; Claudia García-Arumí Fusté; Luis García-Onrubia; Sergio Copete; José García-Arumí
Journal:  Clin Ophthalmol       Date:  2020-06-16

Review 6.  Optic disk pit maculopathy: current management strategies.

Authors:  Irini Chatziralli; Panagiotis Theodossiadis; George P Theodossiadis
Journal:  Clin Ophthalmol       Date:  2018-08-10

7.  Autologous platelet concentrate in surgery for macular detachment associated with congenital optic disc pit.

Authors:  Jeroni Nadal; Marta S Figueroa; Elisa Carreras; Patricia Pujol; Maria Isabel Canut; Rafael Ignacio Barraquer
Journal:  Clin Ophthalmol       Date:  2015-10-22

8.  Optic Disc Pit Maculopathy - Case Series, Clinical Approach, and Management.

Authors:  Dimitrios Kalogeropoulos; Soon Wai Ch'ng; Rynn Lee; Ibrahim Elaraoud; Vinaya Felicida; Maninee Purohit; Maggie Mathew; Naduviledeth Ajith-Kumar; Ash Sharma; Arijit Mitra
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.